Pharvaris (PHVS) Cash from Investing Activities (2020 - 2026)

Pharvaris (PHVS) reported Cash from Investing Activities of -$60992.3 for Q1 2026, up 63.99% on a YoY basis from -$37193.7 in Q1 2025, and down 3306.82% quarter-over-quarter from -$1790.3 in Q4 2025.

Pharvaris (PHVS) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Pharvaris has reported Cash from Investing Activities for 7 years, with the latest figure at -$60992.3 in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities rose 63.99% year-over-year to -$60992.3; the trailing twelve-month figure through Mar 2026 stood at $5.4 billion (up 254.53% YoY), and the FY2025 full-year result was -$185988.4, up 68.06% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$60992.3, down from -$1790.3 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $168.8 billion in Q3 2025, with the low at -$163.4 billion in Q2 2025.
  • Historically, Cash from Investing Activities has averaged $402.8 million across 5 years, with a median of -$30535.2 in 2023.
  • The largest YoY upside for Cash from Investing Activities was 114742419.94% in 2023 against a maximum downside of 236328759.87% in 2023.
  • Pharvaris' Cash from Investing Activities stood at -$24117.6 in 2022, then declined by 26.61% to -$30535.2 in 2023, then sank by 463.14% to -$171955.2 in 2024, then soared by 98.96% to -$1790.3 in 2025, then tumbled by 3306.82% to -$60992.3 in 2026.
  • The last three Cash from Investing Activities figures came in at -$60992.3 (Q1 2026), -$1790.3 (Q4 2025), and $168.8 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -2.89 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -431.90 Mn
9 Abivax 90.15 Bn 90.15 Bn - 579,519.10
10 Pharvaris 28.66 Bn 28.37 Bn - -60,992.34

Historic Data

Download Data
DateValue
Mar 31, 2026 -60,992.34
Mar 31, 2026 -60,992.34
Dec 31, 2025 -1,790.30
Dec 31, 2025 -1,790.30
Sep 30, 2025 168.77 Bn
Sep 30, 2025 168.77 Bn
Jun 30, 2025 -163.42 Bn
Jun 30, 2025 -163.42 Bn
Mar 31, 2025 -169,356.55
Mar 31, 2025 -169,356.55
Dec 31, 2024 -171,955.17
Dec 31, 2024 -171,955.17
Sep 30, 2024 77.80 Bn
Sep 30, 2024 77.80 Bn
Jun 30, 2024 -76.29 Bn
Jun 30, 2024 -76.29 Bn
Mar 31, 2024 -33,360.00
Mar 31, 2024 -33,360.00
Dec 31, 2023 -30,535.17
Dec 31, 2023 -30,535.17